Anglia Ruskin University

Recent trials of the iNKT cell therapy agenT-797 have demonstrated significant improvements in survival rates for critically ill COVID-19 patients with ARDS. This innovative treatment, which bolsters the immune response and reduces inflammation, offers hope for broader applications beyond COVID-19. Credit: SciTechDaily.comInitial trial suggests invariant natural killer cell therapy improves survival.Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill…

A study found that women currently using oral contraceptive pills report lower rates of depression compared to former users. The study, involving 6,239 American women, suggests that alleviating pregnancy concerns and a potential ‘survivor bias’ could explain this difference.Researchers analyzed data from 6,239 women in the United States in a new study.A recent study revealed that women using oral contraceptive pills (OCP) are less likely to experience depression.The study analyzed data from 6,239 women in the United…